J. Vermylen

1.3k total citations
59 papers, 983 citations indexed

About

J. Vermylen is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J. Vermylen has authored 59 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 15 papers in Pulmonary and Respiratory Medicine and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J. Vermylen's work include Antiplatelet Therapy and Cardiovascular Diseases (12 papers), Blood properties and coagulation (11 papers) and Platelet Disorders and Treatments (9 papers). J. Vermylen is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (12 papers), Blood properties and coagulation (11 papers) and Platelet Disorders and Treatments (9 papers). J. Vermylen collaborates with scholars based in Belgium, Italy and United Kingdom. J. Vermylen's co-authors include H. Claeys, Hans Deckmyn, Marc Verstraete, Maria Benedetta Donati, J Vandenbroucke, C. Vermylen, Daniël Blockmans, M Verstraete, Dalton A. F. Chamone and Bernard Spitz and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Blood.

In The Last Decade

J. Vermylen

57 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Vermylen Belgium 18 336 223 195 183 175 59 983
J Hauert Switzerland 16 332 1.0× 143 0.6× 177 0.9× 317 1.7× 234 1.3× 37 973
G Blaskó Hungary 15 338 1.0× 98 0.4× 130 0.7× 112 0.6× 106 0.6× 42 670
MJ Broekman United States 10 392 1.2× 209 0.9× 138 0.7× 250 1.4× 71 0.4× 15 1.0k
Mohamed Hatmi France 18 330 1.0× 68 0.3× 132 0.7× 231 1.3× 148 0.8× 39 978
Jan‐Erik Niléhn Sweden 15 439 1.3× 251 1.1× 100 0.5× 69 0.4× 102 0.6× 22 925
Fiona Green United Kingdom 20 494 1.5× 622 2.8× 247 1.3× 261 1.4× 308 1.8× 32 2.0k
Herbert Lau Canada 15 257 0.8× 102 0.5× 283 1.5× 198 1.1× 127 0.7× 37 849
M R Elstad United States 10 404 1.2× 104 0.5× 222 1.1× 198 1.1× 123 0.7× 10 1.2k
Ichiro Kumabashiri Japan 18 409 1.2× 228 1.0× 126 0.6× 190 1.0× 322 1.8× 44 1.4k
C. Caranobe France 19 345 1.0× 123 0.6× 294 1.5× 366 2.0× 70 0.4× 57 984

Countries citing papers authored by J. Vermylen

Since Specialization
Citations

This map shows the geographic impact of J. Vermylen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Vermylen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Vermylen more than expected).

Fields of papers citing papers by J. Vermylen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Vermylen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Vermylen. The network helps show where J. Vermylen may publish in the future.

Co-authorship network of co-authors of J. Vermylen

This figure shows the co-authorship network connecting the top 25 collaborators of J. Vermylen. A scholar is included among the top collaborators of J. Vermylen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Vermylen. J. Vermylen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oury, Cécile, Emese Tóth-Zsámboki, J. Vermylen, & Marc Hoylaerts. (2006). The Platelet ATP and ADP Receptors. Current Pharmaceutical Design. 12(7). 859–875. 37 indexed citations
2.
Ulrichts, Hans, Jolán Hársfalvi, László Bene, et al.. (2004). A monoclonal antibody directed against human von Willebrand factor induces type 2B‐like alterations. Journal of Thrombosis and Haemostasis. 2(9). 1622–1628. 11 indexed citations
3.
Steenbergen, W. Van & J. Vermylen. (1995). Reversible hypoprothrombinemia in a patient with primary biliary cirrhosis treated with rifampicin.. PubMed. 90(9). 1526–8. 6 indexed citations
4.
Vandermeulen, Erik, Hugo Van Aken, & J. Vermylen. (1995). Anticoagulants and Spinal-Epidural Anesthesia. Survey of Anesthesiology. 39(5). 311???312–311???312. 25 indexed citations
5.
Zachée, Pierre, J. Vermylen, & M. Boogaerts. (1994). Hematologic aspects of end-stage renal failure. Annals of Hematology. 69(1). 33–40. 32 indexed citations
6.
Tornai, István, Jef Arnout, Hans Deckmyn, Kathelijne Peerlinck, & J. Vermylen. (1993). A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.. Journal of Clinical Investigation. 91(1). 273–282. 18 indexed citations
7.
Verhaeghe, Rik, Guy Wilms, Peter Mombaerts, et al.. (1987). FEMORO-POPLITEAL ARTERY THROMBOLYSIS WITH INTRA-ARTERIAL INFUSION OF RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR (rt-PA). Thrombosis and Haemostasis. 1 indexed citations
8.
Arnout, Jozef, et al.. (1987). Continuous Inhibition of Serotonin-Induced Platelet Aggregation during Chronic Ketanserin Administration to Man Can Be Detected after Plasma pH Control. Pathophysiology of Haemostasis and Thrombosis. 17(6). 344–348. 3 indexed citations
9.
Verhaeghe, Raymond, Guy Wilms, & J. Vermylen. (1987). Local Low-Dose Thrombolysis in Arterial Disease of the Limbs. Seminars in Thrombosis and Hemostasis. 13(2). 206–211. 2 indexed citations
10.
Gresele, Paolo, et al.. (1985). Thromboxane A2 and prostacyclin do not modulate the systemic hemodynamic response to cold in humans.. PubMed. 106(5). 534–41. 5 indexed citations
11.
Deckmyn, Hans, Willem Proesmans, & J. Vermylen. (1983). Prostacyclin production by whole blood from children : Impairment in the hemolytic uremic syndrome and excessive formation in chronic renal failure. Thrombosis Research. 30(1). 13–18. 4 indexed citations
12.
Boogaerts, M., J. Vermylen, Hans Deckmyn, et al.. (1983). Enkephalins Modify Granulocyte-Endothelial Interactions by Stimulating Prostacyclin Production. Thrombosis and Haemostasis. 50(2). 572–575. 25 indexed citations
13.
Serruys, Patrick W., et al.. (1983). Acute effect of cigarette smoking on cardiac prostaglandin synthesis and platelet behavior in patients with coronary heart disease.. PubMed. 11. 359–64. 7 indexed citations
14.
Chamone, Dalton A. F., Bart Van Damme, L Carreras, & J. Vermylen. (1981). Increased Release of Vascular Prostacyclin-Like Activity after Long-Term Treatment of Diabetic Rats with Bay g 6575. Pathophysiology of Haemostasis and Thrombosis. 10(6). 297–303. 8 indexed citations
15.
Donati, Maria Benedetta, et al.. (1979). Action of Brinase on Human Fibrinogen and Plasminogen. Thrombosis and Haemostasis. 42(2). 571–581. 4 indexed citations
16.
Verstraete, M, J. Vermylen, William H. Holleman, & Grant H. Barlow. (1977). Biological effects of the administration of an equimolar streptokinase-plasminogen complex in man. Thrombosis Research. 11(2). 227–236. 15 indexed citations
17.
Chamone, D.A.F. & J. Vermylen. (1977). The Induction of Platelet Aggregates in Healthy Subjects by Venousocclusion. Thrombosis and Haemostasis. 1 indexed citations
18.
Vermylen, J., et al.. (1975). Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experiments.. PubMed. 216(1). 263–79. 18 indexed citations
19.
Gaetano, Giovanni de, et al.. (1974). Indomethacin and Platelet Aggregation in Chronic Glomerulonephritis: Existence of Non-responders. BMJ. 2(5914). 301–303. 10 indexed citations
20.
Verstraete, Marc, C. Vermylen, J. Vermylen, & J Vandenbroucke. (1965). Excessive consumption of blood coagulation components as cause of hemorrhagic diathesis. The American Journal of Medicine. 38(6). 899–908. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Hauert Breakdown of academic impact, for papers by G Blaskó Breakdown of academic impact, for papers by MJ Broekman Breakdown of academic impact, for papers by Mohamed Hatmi Breakdown of academic impact, for papers by Jan‐Erik Niléhn Breakdown of academic impact, for papers by Fiona Green Breakdown of academic impact, for papers by Herbert Lau Breakdown of academic impact, for papers by M R Elstad Breakdown of academic impact, for papers by Ichiro Kumabashiri Breakdown of academic impact, for papers by C. Caranobe
Rankless by CCL
2026